Author: The Phage News

BiomX, a company developing natural and engineered phages, has announced positive results in clinical trials. BiomX has announced the safety and efficacy results from…

Phages—viruses that specifically target and eliminate bacteria—offer a highly targeted approach to infection control, reducing the risk of harming beneficial microbiota. With the “silent…

The Targeting Phage Therapy organization has announced the 8th World Conference which will be held on June 10-11, 2025 at DoubleTree by Hilton Berlin…

From the ancient times, turmeric has gained its notoriety as an effective antibacterial, anti-inflammatory, anti-oxidant spice. The yellow compound, curcumin, isolated from rhizomes of…

Two phage-based vaccine candidates for avian influenza (H5N1) developed by Cytophage are now entering preclinical trials. Cytophages’ innovative phage technology uses distinct antigen presentation…

“The Phage Art Competition, 2024” comes to an end and The Phage is excited to announce the finalists. The Competition began on 1-December-2024 and…

The Phage Genome Analysis and Comparative Genomics Workshop hosted by the Phage Hunters Training and Research Program conducted for 10 days in February 2025…

Over the past 100 years, antibiotics have drastically changed modern medicine. “The introduction of antibiotics into clinical use was arguably the greatest medical breakthrough…